We are live on
!
Find out more
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
CORV
Delisted
CORV was delisted on the 26th of May, 2020.
27 hedge funds and large institutions have $1.65M invested in Correvio Pharma Corp. Ordinary Shares (Canada) in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
40% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 5
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less capital invested
Capital invested by funds: $1.87M → $1.65M (-$218K)
13% less funds holding
Funds holding: 31 → 27 (-4)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
27
Holders Change
-4
Holders Change %
-12.9%
% of All Funds
0.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
4
Increased
7
Reduced
5
Closed
7
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
+$3K
Top Buyers
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$861K |
| 2 |
JC
JBF Capital
Aspen,
Colorado
|
+$132K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$28K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$23.9K |
| 5 |
CIBC World Market
Toronto,
Ontario, Canada
|
+$17K |
Top Sellers
| 1 |
TA
Tamarack Advisers
Carlsbad,
California
|
-$1.02M |
| 2 |
AIP
ARS Investment Partners
New York
|
-$61K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$48K |
| 4 |
RA
Royce & Associates
New York
|
-$41K |
| 5 |
Morgan Stanley
New York
|
-$34.7K |
